BioSpace News Archive

On Tuesday, key US indices were mixed as the NASDAQ Composite finished the trading session down 0.01%; the Dow Jones Industrial Average edged 0.79% higher; and the S&P 500 was up 0.48%.

Clearance allowing the test to be sold as an in vitro diagnostic for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.

The company is best known for its industry-leading nutritional supplement brands Nugenix®, Instaflex®, Peptiva®, and Lumiday®

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the pivotal Phase 3 KEYNOTE-048 trial investigating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC), met a primary endpoint of overall survival (OS) as monotherapy in patients whose tumors expressed PD-L1 (Combined Proportion Score (CPS) ≥20).

Program focuses on infectious disease assays - including HIV - for countries where critical testing is needed most

Q2 revenue of $2.9 billion, up 13% over $2.5 billion last year

Researchers at Georgia Tech Uncover How the Brain Reacts to Seeing Insects and Other Pests

Barco Uniforms’ Barco One™ Wellness raises the bar on delivering purposeful technology, comfort and style to help health care professionals feel their best and improve performance on the job

Company also provides anticipated timing update for closing of its Recapitalization Transaction

Florida-based institution among first community hospitals improving patient care, eliminating waste, and cutting costs with AI